Potential advantages of DNA immunization for influenza epidemic and pandemic planning

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 225-229

  Webster, Robert G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; CONFERENCE PAPER; CROSS REACTION; DRUG SAFETY; EPIDEMIC; GENE GUN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0033007597     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515123     Document Type: Conference Paper

References (26)

1. 1. Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993;11:957-60.
2. 2. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
3. 3. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997;13:617-48.
4. 4. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
5. 5. Tang D-C, Devit M, Johnson SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356:152.
6. 6. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-82.
7. 7. Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990;87:9568-72.
8. 8. Montgomery DL, Shiver JW, Leander KR, et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 1993;12:777-83.
9. 9. Donnelly JJ, Friedman A, Martinez D, et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995;1:583-7.
10. 10. Robinson HL, Boyle CA, Feltquate DM, Morin MJ, Santoro JC, Webster RG. DNA immunization for influenza virus: studies using hemagglutinin and nucleoprotein-expressing DNAs. J Infect Dis 1997;176(suppl): S50-5.
11. 11. Justewicz DM, Webster RG. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology 1996;224:10-7.
12. 12. Boyle CM, Morin M, Webster RG, Robinson HL. Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus HI glycoprotein. J Virol 1996;70:9074-8.
13. 13. Webster RG, Fynan EF, Santoro JC, Robinson HL. Protection of ferrets against influenza challenge with a DNA vaccine to the hemagglutinin. Vaccine 1994;12:1495-8.
14. 14. Pisetsky DS, Reich C, Crowley SD, et al. Immunological properties of bacterial DNA. Ann NY Acad Sci 1995;772:152-63.
15. 15. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different TH cell-types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997;158:2278-84.
16. 16. Fuller DH, Haynes JR. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses 1996;10:1433-41.
17. 17. Xiang Z, Ertl HCJ. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995;2:129-35.
18. 18. Ramshaw IA, Leong KH, Ramsay AJ, Boyle DB. Induction of protective immunity against influenza virus using DNA and recombinant avipox-virus vectors. In: Brown LE, Hampson AW, Webster RG, eds. Options for the control of influenza III. New York: Elsevier Science, 1996: 772-6.
19. 19. Robertson JS. Safety considerations for nucleic acid vaccines. Vaccine 1994;12:1526-8.
20. 20. Parker SE, Vahlsing LH, Serfilippi LM, et al. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates. Hum Gene Ther 1995;6:575-90.
21. 21. Nabel GJ, Nabel EG, Yang ZY, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993;90:11307-11.
22. 22. Mor G, Klinman DM, Shapiro S, et al. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol 1995;155: 2039-46.
23. 23. Wang Y, Xiang Z, Pasquini S, Ertl HCJ. Immune response to neonatal genetic immunization. Virology 1997;228:278-84.
24. 24. Griffiths E. Assuring the safety and efficacy of DNA vaccines. Ann NY Acad Sci 1995;772:152-63.
25. 25. Nichols W, Ledwith B, Mann S, Troilo PJ. Potential DNA vaccination into host cell genome. Ann NY Acad Sci 1995;772:30-9.
26. 26. Braciale TJ. Naked DNA and vaccine design. Trends Microbiol 1993;1:323-4.